Clinical Trials Directory

Trials / Unknown

UnknownNCT04445298

Skin Barrier Assessment in Pregnancy and at Birth

Status
Unknown
Phase
Study type
Observational
Enrollment
160 (estimated)
Sponsor
National Jewish Health · Academic / Other
Sex
All
Age
0 Minutes – 55 Years
Healthy volunteers
Accepted

Summary

This is a prospective birth cohort study assessing the role of maternal and environmental factors on the development of allergic diseases in children. Pregnant mothers will be enrolled and we will examine her skin barrier with skin tape strips (STS) and transepidermal water loss (TEWL), along with blood work. We will then follow her offspring and perform similar testing, along with detailed questionnaires inquiring about exposures such as use of detergents and soaps, sunlight exposure, and pollution exposure. When the infant is around 12 months old, we will contact the family via telephone to see if the child developed any allergic conditions within their first year of life, such as eczema, food allergy, or wheezing. A final questionnaire will be performed.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTTransepidermal water lossWe will assess the skin with transepidermal water loss (TEWL) by using a condenser-chamber system placed lightly on the skin. This will be performed at baseline, then after every 4 skin tape strips.
DIAGNOSTIC_TESTSkin tape strippingAdhesive skin sampling discs will be pressed against the skin in a hairless location followed by lifting it free of the skin. The discs will be evaluated for lipid content, protein, and filaggrin byproducts in the collected skin sample.
DIAGNOSTIC_TESTBlood drawWe will draw blood to look at the vitamin D, total immunoglobulin E (IgE), and the filaggrin gene which is important in maintaining the skin barrier.
DIAGNOSTIC_TESTBacterial PCR swabSkin swab from the superficial skin will be collected to be assessed in the laboratory via PCR for the presence of staphylococcus aureus.

Timeline

Start date
2020-08-03
Primary completion
2022-07-01
Completion
2022-07-01
First posted
2020-06-24
Last updated
2020-09-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04445298. Inclusion in this directory is not an endorsement.